Morgan Stanley’s Clover Health Investments, Corp. Warrants CLOVW Stock Holding History

Morgan Stanley’s Portfolio CLOVW Stock Details CLOVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,547	Closed	-$79K	–	8217
2021 Q2	$79K	Buy	15,547 +878	+6%	+$2.87K	﹤0.01%	6459
2021 Q1	$24K	Buy	14,669 +13,016	+787%	+$37.1K	﹤0.01%	6669
2020 Q4	$7K	Buy	+1,653	New	+$3.91K	﹤0.01%	6730

Morgan Stanley's CLOVW Position: Q3 2021 in Review

Morgan Stanley sold out of Clover Health Investments, Corp. Warrants (CLOVW) in Q3 2021, closing a stake of 15,547 shares — an estimated $79K sold.

Morgan Stanley first reported a position in CLOVW in Q4 2020 and held it in 3 quarters. The position peaked at $79K in Q2 2021. 0 funds tracked by Wall St. Rank hold CLOVW as of Q3 2021.

Morgan Stanley reported no remaining Clover Health Investments, Corp. Warrants position as of Q3 2021 after selling out during the quarter.
Morgan Stanley sold 15,547 Clover Health Investments, Corp. Warrants shares in Q3 2021, an estimated $79K.
Morgan Stanley first reported a position in Clover Health Investments, Corp. Warrants in Q4 2020 and held it in 3 quarters.
Morgan Stanley's Clover Health Investments, Corp. Warrants position peaked at $79K in Q2 2021.
0 funds tracked by Wall St. Rank held Clover Health Investments, Corp. Warrants as of Q3 2021.

Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.